Clinical Trial Update: Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2) [Phase 3]

View source ↗

Summary

Phase 3 trial update for treatment of acute ischemic stroke using edaravone dexborneol (TASTE-2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Edaravone Dexborneol

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke, Mechanical Thrombectomy | Phase 3 | Status: COMPLETED